Resources from the same session
Emerging targets in metastatic breast cancer: What have we learnt from molecular analysis?
Presenter: Sherene Loi
Session: Next generation therapies in metastatic breast cancer
Resources:
Slides
Webcast
New generation antibody drug conjugates (ADCs)
Presenter: Ian Krop
Session: Next generation therapies in metastatic breast cancer
Resources:
Slides
Webcast
Expanding indications of DNA damage agents
Presenter: Andrew Tutt
Session: Next generation therapies in metastatic breast cancer
Resources:
Slides
Webcast
What comes after anti-PD1?
Presenter: Giuseppe Curigliano
Session: Next generation therapies in metastatic breast cancer
Resources:
Slides
Webcast